(1)
Formulation and Optimization of Liquisolid Tablet for Improving the Dissolution Profile of Rivaroxaban by Using DoE Approachand Antithrombic Activity. JOC 2025, 24 (3s), 812-830. https://doi.org/10.64149/J.Carcinog.24.3s.812-830.